Literature DB >> 21266110

Identification of nucleolar and coiled-body phosphoprotein 1 (NOLC1) minimal promoter regulated by NF-κB and CREB.

Xuesong Gao1, Qi Wang, Wei Li, Biao Yang, Hao Song, Wei Ju, Shunai Liu, Jun Cheng.   

Abstract

Nucleolar and coiled-body phosphoprotein 1 (NOLC1) is a phosphoprotein that transiently associates with the mature nucleolar H/ACA and C/D box small nucleolar ribonucleoproteins (snoRNPs). Several lines of evidence indicate that NOLC1 plays an important role in the synthesis of rRNA and the biosynthesis of ribosomes. In the present study, we examined the transcriptional regulation mechanisms that govern the expression of NOLC1. We first performed functional dissection of the NOLC1 promoter. We demonstrated that transcription factors NF-κB and CREB could bind to the minimal NOLC1 promoter. This was demonstrated by electrophoretic mobility shift assays and chromatin immunoprecipitation. Mutagenesis and overexpression assays revealed that NF-κB and CREB positively regulated the NOLC1 promoter. These findings may provide new insight into the mechanisms that regulate NOLC1 expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266110     DOI: 10.5483/BMBRep.2011.44.1.70

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  11 in total

Review 1.  Linker histone H1 and protein-protein interactions.

Authors:  Anna A Kalashnikova; Ryan A Rogge; Jeffrey C Hansen
Journal:  Biochim Biophys Acta       Date:  2015-10-08

2.  Mechanism of PKA-dependent and lipid-raft independent stimulation of Connexin43 expression by oxytoxin in mouse embryonic stem cells.

Authors:  Seung Pil Yun; Su Shin Park; Jung Min Ryu; Jae Hong Park; Mi Ok Kim; Jang-Hern Lee; Ho Jae Han
Journal:  Mol Endocrinol       Date:  2012-05-07

3.  Enhanced NOLC1 promotes cell senescence and represses hepatocellular carcinoma cell proliferation by disturbing the organization of nucleolus.

Authors:  Fuwen Yuan; Yu Zhang; Liwei Ma; Qian Cheng; Guodong Li; Tanjun Tong
Journal:  Aging Cell       Date:  2017-05-10       Impact factor: 9.304

4.  Complex harmonic regularization with differential evolution in a memetic framework for biomarker selection.

Authors:  Sai Wang; Hai-Wei Shen; Hua Chai; Yong Liang
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

5.  Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis.

Authors:  Wenbin Chen; Shengren Cen; Xumin Zhou; Taowei Yang; Kaihui Wu; Libin Zou; Junqi Luo; Chuanyin Li; Daojun Lv; Xiangming Mao
Journal:  Front Cell Dev Biol       Date:  2021-01-08

6.  A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma.

Authors:  Chen-Yan Wu; Lei Li; Shi-Lu Chen; Xia Yang; Chris Zhiyi Zhang; Yun Cao
Journal:  Cell Death Dis       Date:  2021-03-25       Impact factor: 8.469

7.  HIF-1-dependent induction of Jumonji domain-containing protein (JMJD) 3 under hypoxic conditions.

Authors:  Ho-Youl Lee; Kang Choi; Hookeun Oh; Young-Kwon Park; Hyunsung Park
Journal:  Mol Cells       Date:  2014-01-27       Impact factor: 5.034

8.  FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter.

Authors:  Kai Qian; Jinqian Zhang; Jingbo Lu; Wenjun Liu; Xingxing Yao; Qing Chen; Shun Lu; Guoan Xiang; Hao Liu
Journal:  Oncol Rep       Date:  2015-12-10       Impact factor: 3.906

9.  NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension.

Authors:  Hai-Jian Sun; Xing-Sheng Ren; Xiao-Qing Xiong; Yun-Zhi Chen; Ming-Xia Zhao; Jue-Jin Wang; Ye-Bo Zhou; Ying Han; Qi Chen; Yue-Hua Li; Yu-Ming Kang; Guo-Qing Zhu
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

10.  Knockdown of NOLC1 Inhibits PI3K-AKT Pathway to Improve the Poor Prognosis of Esophageal Carcinoma.

Authors:  Fanguo Kong; Yansheng Shang; Xingyuan Diao; Jiaguo Huang; Hui Liu
Journal:  J Oncol       Date:  2021-05-08       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.